Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mdm2 binds p73 alpha without targeting degradation.

E Bálint1, S Bates, K H Vousden

  • 1ABL Basic Research Program, NCI-FCRDC, Frederick, Maryland, 21702-1202, USA.

Oncogene
|August 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Effectiveness and cost effectiveness of a stress management training for leaders of small and medium sized enterprises - study protocol for a randomized controlled-trial.

BMC public health·2021
Same author

The impact of different hair-removal behaviours on the biophysical and biochemical characteristics of female axillary skin.

International journal of cosmetic science·2020
Same author

Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study.

British journal of anaesthesia·2019
Same author

Correction to: Cardiopulmonary exercise testing (CPET) in the United Kingdom-a national survey of the structure, conduct, interpretation and funding.

Perioperative medicine (London, England)·2018
Same author

Cardiopulmonary exercise testing (CPET) in the United Kingdom-a national survey of the structure, conduct, interpretation and funding.

Perioperative medicine (London, England)·2018
Same journal

SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.

Oncogene·2026
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
See all related articles

The tumor suppressor p73 alpha interacts with Mdm2, but unlike p53, it is not degraded. This interaction inhibits p73 alpha

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Tumor Suppressor Proteins

Background:

  • The p53 tumor suppressor protein's function is regulated by Mdm2, leading to its degradation.
  • Understanding the regulation of related proteins like p73 alpha is crucial for cancer research.

Purpose of the Study:

  • To investigate the interaction between p73 alpha and Mdm2.
  • To determine if Mdm2 binding affects p73 alpha stability and function.
  • To compare the regulatory mechanisms of p73 alpha and p53.

Main Methods:

  • In vitro binding assays.
  • Cellular interaction studies.
  • Analysis of protein degradation pathways.
  • Transcriptional activity assays.

Related Experiment Videos

Main Results:

  • p73 alpha forms an interaction with Mdm2 in vitro and in cells.
  • This interaction does not lead to the degradation of p73 alpha.
  • Human papillomavirus E6 protein also fails to degrade p73 alpha.
  • Mdm2 binding impedes p73 alpha's transcriptional function despite the absence of degradation.

Conclusions:

  • p73 alpha stability is regulated by mechanisms distinct from p53.
  • Mdm2 interaction with p73 alpha inhibits its transcriptional activity without causing degradation.
  • These findings shed light on the unique regulatory pathways of p73 alpha in cancer.